Literature DB >> 25550909

EphB4 expression in pterygium is associated with microvessel density.

Chunyan Xue1, Yueqin Chen1, Zhenping Huang1, Yirui Ge1, Haiyan Wang2, Jiandong Wang2.   

Abstract

OBJECTIVE: Angiogenesis is a key component of the pathogenesis process of pterygium, which is the growth of fibrovascular tissue on the cornea. It has been reported that EphB4, a receptor tyrosine kinase of the ephrin-Eph system, plays important role in vascular development during embryogenesis and tumor angiogenesis and is potentially involved in ocular angiogenesis. The aim of this study is to investigate the role of EphB4 in pterygia.
METHODS: Fifteen pterygium samples and their paired upper bulbar conjunctiva were evaluated for expression of EphB4 and CD31 by using immunohistochemical staining. The expression level of the mRNA of EphB4 gene in 7 pterygia and matched upper bulbar conjunctiva was evaluated by using a quantitative real-time RT-PCR analysis. Microvessel density (MVD) was assessed with antibody that targets CD31.
RESULTS: EphB4 protein was high expressed in the epithelium and stroma of pterygia compared to those in upper bulbar conjunctiva. Immunohistochemical staining showed that pterygia presented with statistically significant higher average count of microvessel compared to normal conjunctivae (28.24 ± 6.79 vs 11.09 ± 2.96 per high power field, P < 0.001). MVD values in stroma of the pterygium and normal conjunctiva presented a significant correlation with EphB4 staining (P < 0.001). Compared with autologous upper bulbar conjunctiva grafts, the expression of the EphB4 mRNA was increased in pterygia in 4 paired samples, including those 3 recurrent ones.
CONCLUSION: The expression of EphB4 in pterygium was significantly related with the increased MVD and may be involved in angiogenesis. EphB4 protein is a potential target for treatment of pterygium.

Entities:  

Keywords:  EphB4; MVD; Pterygium; angiogenesis

Year:  2014        PMID: 25550909      PMCID: PMC4276167     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  43 in total

Review 1.  The treatment of pterygium.

Authors:  Lawrence W Hirst
Journal:  Surv Ophthalmol       Date:  2003 Mar-Apr       Impact factor: 6.048

2.  Expression of p63 in pterygium and normal conjunctiva.

Authors:  Pornpilas Sakoonwatanyoo; Donald T H Tan; Duncan R Smith
Journal:  Cornea       Date:  2004-01       Impact factor: 2.651

3.  EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.

Authors:  Ralf Erber; Uta Eichelsbacher; Violetta Powajbo; Tobias Korn; Valentin Djonov; Jihong Lin; Hans-Peter Hammes; Rainer Grobholz; Axel Ullrich; Peter Vajkoczy
Journal:  EMBO J       Date:  2006-01-19       Impact factor: 11.598

4.  Expression of p63 and p16 in primary and recurrent pterygia.

Authors:  Fernando S Ramalho; Claudia Maestri; Leandra N Z Ramalho; Alfredo Ribeiro-Silva; Erasmo Romão
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-08       Impact factor: 3.117

Review 5.  The science of pterygia.

Authors:  J C Bradley; W Yang; R H Bradley; T W Reid; I R Schwab
Journal:  Br J Ophthalmol       Date:  2009-06-09       Impact factor: 4.638

6.  Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization.

Authors:  Shikun He; Yi Ding; Jiehao Zhou; Valery Krasnoperov; Sergey Zozulya; S Ram Kumar; Stephen J Ryan; Parkash S Gill; David R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-12       Impact factor: 4.799

7.  The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis.

Authors:  Georg Martiny-Baron; Philipp Holzer; Eric Billy; Christian Schnell; Joseph Brueggen; Mireille Ferretti; Niko Schmiedeberg; Jeanette M Wood; Pascal Furet; Patricia Imbach
Journal:  Angiogenesis       Date:  2010-08-29       Impact factor: 9.596

8.  Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.

Authors:  Nicole K Noren; Mark Lu; Andrew L Freeman; Mitchell Koolpe; Elena B Pasquale
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-05       Impact factor: 11.205

9.  Inhibition of tumor growth and angiogenesis by soluble EphB4.

Authors:  Georg Martiny-Baron; Thomas Korff; Florence Schaffner; Norbert Esser; Stefan Eggstein; Dieter Marmé; Hellmut G Augustin
Journal:  Neoplasia       Date:  2004 May-Jun       Impact factor: 5.715

10.  Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.

Authors:  H U Wang; Z F Chen; D J Anderson
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

View more
  4 in total

Review 1.  The Role of Eph Receptors and Ephrins in Corneal Physiology and Diseases.

Authors:  Radoslaw Kaczmarek; Katarzyna Zimmer; Pawel Gajdzis; Malgorzata Gajdzis
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

2.  Proliferative Effects of Histamine on Primary Human Pterygium Fibroblasts.

Authors:  Zhenwei Qin; Qiuli Fu; Lifang Zhang; Houfa Yin; Xiuming Jin; Qiaomei Tang; Danni Lyu; Ke Yao
Journal:  Mediators Inflamm       Date:  2016-10-30       Impact factor: 4.711

3.  BMP6 Regulates Corneal Epithelial Cell Stratification by Coordinating Their Proliferation and Differentiation and Is Upregulated in Pterygium.

Authors:  Anil Tiwari; Sudha Swamynathan; Gregory Campbell; Vishal Jhanji; Shivalingappa K Swamynathan
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

4.  Shear stress promotes differentiation of stem cells from human exfoliated deciduous teeth into endothelial cells via the downstream pathway of VEGF-Notch signaling.

Authors:  Penglai Wang; Shaoyue Zhu; Changyong Yuan; Lei Wang; Jianguang Xu; Zongxiang Liu
Journal:  Int J Mol Med       Date:  2018-07-06       Impact factor: 4.101

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.